TMEM106B and frontotemporal dementia: Consistent with previous studies, we found that iMGs from FTD–GRN patients resulted in lysosomal enlargement and dysregulated markers of lysosomes along with increased lysosomal protein levels such as SORT1 and TMEM106B.